Abstract:Androgen insensitivity syndrome (AIS) is a rare Mendelian disorder caused by mutations of the androgen receptor (AR) gene on the long arm of the X chromosome. As a result of the mutation, the receptor becomes resistant to androgens, and hence, karyotypically male patients (46,XY) carry a female phenotype. Their cryptorchid gonads are prone to the development of several types of tumors (germ cell, sex cord stromal, and others). Here, we report a 15-year-old female-looking patient with primary amenorrhea who underwent laparoscopic gonadectomy. Histologically, the patient's gonads showed Sertoli cell hamartomas (SCHs) and adenomas (SCAs) with areas of Sertoli–Leydig cell tumors (SLCTs) and a left-sided paratesticular leiomyoma. Rudimentary Fallopian tubes were also present. The patient's karyotype was 46,XY without any evidence of aberrations. Molecular genetic analysis of the left gonad revealed two likely germline mutations—a pathogenic frameshift deletion in the AR gene (c.77delT) and a likely pathogenic missense variant in the RAC1 gene (p.A94V). Strikingly, no somatic mutations, fusions, or copy number variations were found. We also performed the first systematic literature review (PRISMA guidelines; screened databases: PubMed, Scopus, Web of Science; ended on 7 December 2023) of the reported cases of patients with AIS showing benign or malignant Sertoli cell lesions/tumors in their gonads (n = 225; age: 4–84, mean 32 years), including Sertoli cell hyperplasia (1%), Sertoli cell nodules (6%), SCHs (31%), SCAs (36%), Sertoli cell tumors (SCTs) (16%), and SLCTs (4%). The few cases (n = 14, 6%; six SCAs, four SCTs, two SLCTs, and two SCHs) with available follow-up (2–49, mean 17 months) showed no evidence of disease (13/14, 93%) or died of other causes (1/14, 7%) despite the histological diagnosis. Smooth muscle lesions/proliferations were identified in 19 (8%) cases (including clearly reported rudimentary uterine remnants, 3 cases; leiomyomas, 4 cases). Rudimentary Fallopian tube(s) were described in nine (4%) cases. Conclusion: AIS may be associated with sex cord/stromal tumors and, rarely, mesenchymal tumors such as leiomyomas. True malignant sex cord tumors can arise in these patients. Larger series with longer follow-ups are needed to estimate the exact prognostic relevance of tumor histology in AIS.

Androgen insensitivity syndrome and metabolic syndrome.

Recent advances in clinical management of androgen insensitive syndrome

Novel androgen receptor gene variant containing a frameshift mutation in a patient with complete androgen insensitivity syndrome

Complete androgen insensitivity syndrome caused by a novel mutation in the androgen receptor gene and its mechanism

Growth Curves of Chinese Children with Androgen Insensitivity Syndrome: A Multicenter Registry Study

Study on a Novel Androgen Receptor Gene Mutation Causing Androgen Insensitivity Syndrome

Novel pathogenic variants in the androgen receptor gene associated with androgen insensitivity syndrome identified through exome sequencing and in silico analysis

A case of mild partial androgen insensitivity syndrome in a juvenile boy

Progress on association between low-density lipoprotein receptor and metabolic syndrome

LINE1-mediated epigenetic repression of androgen receptor transcription causes androgen insensitivity syndrome

Novel Androgen Receptor Gene Mutation in Patient with Complete Androgen Insensitivity Syndrome.

Complete androgen insensitivity syndrome coexisting with müllerian duct remnants: a case report and literature review

A Case Report and First Systematic Literature Review

A Large Deletion/insertion-Induced Frameshift Mutation of the Androgen Receptor Gene in a Family with a Familial Complete Androgen Insensitivity Syndrome

Dissecting phenotypic variation among AIS patients.

Male Fertility is Compatible with an Arg(840)Cys Substitution in the AR in a Large Chinese Family Affected with Divergent Phenotypes of AR Insensitivity Syndrome.

Case Report: Surgery and genetic analysis of a complete androgen insensitivity syndrome family with testicular malignant tumors

Significantly improved thermostability of a reductase CgKR1 from Candida glabrata with a key mutation at Asp 138 for enhancing bioreduction of aromatic α-keto esters.

A novel nonsense mutation in the androgen receptor gene causes the complete androgen insensitivity syndrome.

Staining procedure for the detection of microcracks: application to ewe bone.

[Genetic analysis and prenatal diagnosis of a Chinese pedigree affected with Complete androgen insensitivity syndrome due to a novel variant of AR gene]